Regions highlighted as key expansion areas are South-East Asia ex-China, and the Middle East and Africa.
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
On Wednesday, the FDA granted 510(k) clearance to Vivos Therapeutics, Inc.’s (NASDAQ:VVOS) flagship oral medical device, which is used to treat moderate to severe obstructive sleep apnea (OSA) and snoring in children. Recent published studies report up to 10.1 million U.S. children (ages 6-17) are estimated to suffer from pediatric OSA. Vivos’ DNA appliance is non-invasive, safe, comfortable, affordable, and highly effective. It is designed to reduce nighttime snoring and treat moderate to sever
Nvidia, ARM initiated: Wall Street's top analyst calls
Nvidia, ARM initiated: Wall Street's top analyst calls
OnTop partners with dLocal across 27 global high-growth markets
Strategic alliance will streamline currency conversion and improve payment efficiency in emerging markets
Watch These GE Vernova Price Levels as Stock Trading Near Record High
GE Vernova shares will likely remain on watchlists Wednesday after hitting a new record high yesterday following favorable coverage from leading investment banks. Monitor these important chart levels.
How the Fed’s rate decision could unravel a big bond-market recession bet
The stakes for investors are running high ahead of a historic rate cut expected from the Federal Reserve on Wednesday.
PayRetailers expands further into Africa, boosting financial inclusion across eight additional key markets
Leveraging success in Latin America to provide underbanked populations with efficient payment functions, expansion includes Burkina Faso, Cameroon, Kenya, Ivory Coast, Ghana, Senegal, South Africa, Nigeria